News

ASH 2025: Developed antibody boosts immune response against blood cancers and solid cancers

ASH 2025: Home-based monitoring could transform care for patients receiving T-cell redirecting therapies

Study reveals online support lacking for sarcoma patients and their carers

ASH 2025: New findings support a chemo-free approach for treating Ph+ ALL

Enhancing breast cancer screening could help save young women’s lives

Cancer loses its sense of time to avoid stress responses

Researchers develop ultrasensitive method to detect low-frequency cancer mutations

ASH 2025: Study connects Agent Orange exposure to earlier and more severe cases of myelodysplastic syndrome

ASH 2025: Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

ASH 2025: Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

ASH 2025: New combination approach aims to make CAR T more durable in lymphoma

ASH 2025: New data highlights promise of pivekimab sunirine in two aggressive blood cancers ​